The best BÜHLMANN publications at ECCO 2018 Meeting in Vienna - We present the debriefing of this  highly interesting meeting for BÜHLMANN diagnostic products. Numerous ECCO IBD abstracts contained data produced by BÜHLMANN assays, mainly calprotectin and biologics trough levels by Quantum Blue® and by the IBDoc® home test.
BÜHLMANN fCAL® ELISA FDA 510(k) Cleared - BÜHLMANN fCAL® ELISA, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool,  has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US.
NICE releases Medtech Innovation Briefing on calprotectin point of care and home testing for monitoring IBD treatment - This describes the innovative aspect that test results can be acted on more quickly than waiting for standard laboratory tests and could help reduce colonoscopies and clinical appointments.




Colloque GEAI 2018

Date: 25 – 26 June 2018
Location: Paris, France

10e Colloque GEAI 2018

Encontro Sul-Brasileiro de DII 2018

Date: 28- 30 June 2018
Location: Blumenau, SC, Brazil

XI Encontro Sul-Brasileiro de Doenças Inflamatórias Intestinais 2018

PNS 2018

Date: 22 – 25 July 2018
Location: Baltimore, MD, USA

Annual Meeting of the Peripheral Nerve Society 2018

AACC 2018

Date: 29 July – 2 August 2018
Location: Chicago, IL, USA

70th AACC Annual Scientific Meeting & Clinical Lab Expo. Visit us at booth #4563.